Lux Health Tech Acquisition Corp. Class A (LUXA)
$10.04
$0.00 (0.00%)As on 04-Nov-2022 09:30EDT
Market cap
$433 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
21.8
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$20 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-387.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$2.2
-
Face value
--
-
Shares outstanding
34,500,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lux Health Techcquisition Corp. Class A (LUXA)
| 2.4 | 0.3 | 1.1 | 1.7 | -- | -- | -- |
|
BSE Sensex*
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
|---|---|
|
Lux Health Techcquisition Corp. Class A (LUXA)
| -8.8 |
|
S&P Small-Cap 600
| 25.3 |
|
BSE Sensex
| 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lux Health Techcquisition Corp. Class A (LUXA)
|
10.0 | 433.4 | 0.0 | 19.8 | -- | -- | 21.8 | 1.3 |
| 10.4 | 143.3 | 0.0 | 0.5 | -- | -- | -- | 1.5 | |
| 9.1 | 262.5 | 0.0 | 11.9 | -- | 5.5 | 29.5 | 1.2 | |
| 9.3 | 410.6 | 0.0 | 3,322,920.1 | -- | -- | 132.1 | 1.0 | |
| 10.1 | 554.0 | 0.0 | 56.0 | -- | -- | 13.2 | 1.1 | |
| 10.1 | 260.2 | 0.0 | 8.6 | -- | -- | 30.5 | 1.3 | |
| 10.0 | 273.8 | 0.0 | 8.6 | -- | -- | 29.5 | 1.3 |
Shareholding Pattern
View DetailsAbout Lux Health Techcquisition Corp. Class A (LUXA)
Lux Health Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.... It intends to acquire companies in the healthcare and technology industries. The company was incorporated in 2020 and is based in New York, New York. Read more
-
CEO & Director
Mr. Joshua Defonzo
-
CEO & Director
Mr. Joshua Defonzo
-
Headquarters
New York, NY
-
Website
FAQs for Lux Health Techcquisition Corp. Class A (LUXA)
What is the current share price of Lux Health Tech Acquisition Corp Class A (LUXA) Today?
The share price of Lux Health Tech Acquisition Corp Class A (LUXA) is $10.04 (NASDAQ) as of 04-Nov-2022 09:30 EDT. Lux Health Tech Acquisition Corp Class A (LUXA) has given a return of 1.72% in the last 1 years.
What is the current PB & PE ratio of Lux Health Tech Acquisition Corp Class A (LUXA)?
The P/E ratio of Lux Health Tech Acquisition Corp Class A (LUXA) is 21.85 times as on 11-Nov-2022.
The P/B ratio of Lux Health Tech Acquisition Corp Class A (LUXA) is 1.31 times as on 11-Nov-2022, a 3 discount to its peers’ median range of 1.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
3.25
|
-3.21
|
|
2020
|
--
|
--
|
|
2021
|
3.25
|
-3.21
|
|
2020
|
--
|
--
|
What is the 52 Week High and Low of Lux Health Tech Acquisition Corp Class A (LUXA)?
The 52-week high and low of Lux Health Tech Acquisition Corp Class A (LUXA) are Rs -- and Rs -- as of 17-May-2026.
What is the market cap of Lux Health Tech Acquisition Corp Class A (LUXA)?
Lux Health Tech Acquisition Corp Class A (LUXA) has a market capitalisation of $ 433 Mln as on 11-Nov-2022. As per SEBI classification, it is a Small Cap company.
Should I invest in Lux Health Tech Acquisition Corp Class A (LUXA)?
Before investing in Lux Health Tech Acquisition Corp Class A (LUXA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.